United States DC Circuit

In an action by medical researchers challenging newly promulgated guidelines authorizing the National Institutes of Health to fund more research projects involving human embryonic stem cells than it had previously done, dismissal of the complaint is reversed where plaintiffs had standing because the Guidelines intensified the competition for a share in a fixed amount of money, and thus the plaintiffs would have to invest more time and resources to craft a successful grant application.

Appellate Information

• Decided 06/25/2010
• Published 06/25/2010

Judges

Court

• United States DC Circuit

Counsel